tracer.nuclear brings together everything behind a radiopharmaceutical: cyclotrons, synthesis modules, precursors and consumables, and the quality control equipment that lets you release the product.
We believe the end product is not a module or a precursor. It is a finished tracer that leads to the right diagnosis or the right therapy.
The same holds for theranostics. Imaging with the gallium form of a ligand and treating with the lutetium form is one programme, not two. Where a pair exists, this index links both sides.
And we want radiochemists and physicians to understand each other. One side solves for yield, purity and release; the other for image quality, timing and what the scan answers. Both sets of facts belong in one place.